Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Remicade
Remicade
Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta
Endpoints
Mon, 07/24/17 - 10:40 am
Samsung Bioepis
Remicade
FDA
biosimilars
JNJ
GSK
Benlysta
lupus
How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal
Fierce Pharma
Thu, 07/20/17 - 11:18 am
JNJ
Remicade
biosimilars
Pfizer
Inflectra
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Novartis
rheumatoid arthritis
generics
Sandoz
Amgen
Enbrel
JNJ
Remicade
AbbVie
Humira
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
UK watchdog accuses Merck of restricting biosimilar competition
Drug Delivery Business News
Thu, 05/25/17 - 08:44 am
Merck
biosimilars
competition
UK
Remicade
J&J fires off legal salvo to block Samsung's Remicade biosim launch
Fierce Pharma
Fri, 05/19/17 - 11:30 am
JNJ
Samsung Bioepis
Remicade
biosimilar
J&J discloses DOJ investigations into marketing, advisory practices
BioPharma Dive
Thu, 05/11/17 - 11:43 am
JNJ
DOJ
drug marketing
Remicade
Olysio
Simponi
Stelara
U.S. prosecutors zero in on J&J marketing, targeting top immunology, hep C meds
Fierce Pharma
Tue, 05/9/17 - 10:43 pm
JNJ
drug manufacturing
immunology
hepatitis C
Remicade
Simponi
Stelara
Olysio
Second biosimilar of Remicade approved in the US, but J&J not rattled
BioPharma Dive
Mon, 04/24/17 - 10:02 pm
Remicade
JNJ
biosimilars
Renflexis
Merck
Samsung Bioepis
J&J's Remicade sees 'very little' biosim erosion, but payers are sticking it to Xarelto
Fierce Pharma
Tue, 04/18/17 - 09:03 pm
JNJ
Remicade
biosimilars
payers
Xarelto
Inflectra
How Decline in Remicade Is Affecting Merck’s Immunology Revenues
Market Realist
Tue, 03/28/17 - 10:18 am
Merck
Remicade
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
The 3 Most Important Numbers for Johnson & Johnson
Motley Fool
Sun, 03/12/17 - 10:54 am
JNJ
devices
Remicade
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Xtalks
Mon, 02/27/17 - 10:02 pm
Pfizer
Celltrion
biosimilars
Crohn's Disease
Inflectra
Remicade
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Motley Fool
Sat, 02/25/17 - 03:21 pm
JNJ
Remicade
Darzalex
Genmab
Multiple Myeloma
Pfizer, Celltrion pushing for interchangeability with Inflectra
BioPharma Dive
Thu, 02/23/17 - 09:11 am
Pfizer
Celltrion
Inflectra
JNJ
biosimilars
Remicade
Pfizer's New Biosimilar Is Off and Running
Motley Fool
Sat, 02/4/17 - 10:00 am
Pfizer
biosimilars
Remicade
JNJ
Inflectra
rheumatoid arthritis
New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
Marketwatch
Sun, 01/29/17 - 11:57 am
JNJ
earnings
Remicade
biosimilars
J&J optimistic in spite of biosimilar threat
BioPharma Dive
Wed, 10/19/16 - 10:39 am
JNJ
biosimilars
Remicade
Pfizer
rheumatoid arthritis
J&J posts earnings beat, and says pharma future bright, despite threat to Remicade
Yahoo/Reuters
Tue, 10/18/16 - 10:46 am
JNJ
earnings
Remicade
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »